Spontaneous hemothorax caused by rivaroxaban treatment for pulmonary embolism: A case report

Bassem Al Hariri, Ahmad Taher Alharafsheh, Muad Abdi Hassan, Abdulqadir J. Nashwan, Mohamed Gaafar Mohamedali, Hatem Mabrouk Abusriwil · 2023

Read Spontaneous hemothorax caused by rivaroxaban treatment for pulmonary embolism: A case report by Bassem Al Hariri, Ahmad Taher Alharafsheh, Muad Abdi Hassan, Abdulqadir J. Nashwan, Mohamed Gaafar Mohamedali, Hatem Mabrouk Abusriwil (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10714055.txt.

Description

Al Hariri and colleagues report in 2023 a case of spontaneous hemothorax, blood filling the chest cavity, in a patient treated with rivaroxaban for a lung blood clot. Hemothorax is rare and can be fatal, and blood thinners are among its known causes. Newer oral anticoagulants bleed less than older vitamin K drugs overall. Still, some researchers suspect their bleeding episodes can be worse when they happen.

The team argues the timing supports a genuine link between the drug and this bleed. The case reminds clinicians that even safer anticoagulants demand vigilance for hidden bleeding.

Catalog record

CREATORBassem Al Hariri, Ahmad Taher Alharafsheh, Muad Abdi Hassan, Abdulqadir J. Nashwan, Mohamed Gaafar Mohamedali, Hatem Mabrouk Abusriwil
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE10 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10714055

Browse the full library · About the Tower of Babel